3.0.0
946
2025-12-05T22:02:15Z
2025-12-05T22:02:15Z
House
H
HR
2025-02-04
119
https://www.congress.gov/bill/119th-congress/house-bill/946
[Congressional Record Volume 171, Number 23 (Tuesday, February 4, 2025)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. JOYCE of Pennsylvania:H.R. 946.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the U.S. Constitution[Page H460]
- hswm00
Ways and Means Committee
House
Standing
  - Referred To
2025-02-04T17:09:25Z
- hsif00
Energy and Commerce Committee
House
Standing
  - Referred To
2025-02-04T17:09:20Z

- ORPHAN Cures Act
119
1862
S
2025-05-22
Read twice and referred to the Committee on Finance. (text: CR S3119)
  - Related bill
CRS
- 2025-02-06
Sponsor introductory remarks on measure. (CR H535-536)
IntroReferral
B00100
9
Library of Congress
- 2025-02-04
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hswm00
Ways and Means Committee
- 2025-02-04
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2025-02-04
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2025-02-04
Introduced in House
IntroReferral
1000
9
Library of Congress
- J000302
Rep. Joyce, John [R-PA-13]
John
Joyce
R
PA
13
N
- D000230
Rep. Davis, Donald G. [D-NC-1]
Donald
Davis
D
NC
G.
1
2025-02-04
True
- H001082
Rep. Hern, Kevin [R-OK-1]
Kevin
Hern
R
OK
1
2025-02-04
True
- P000608
Rep. Peters, Scott H. [D-CA-50]
Scott
Peters
D
CA
H.
50
2025-02-04
True
- M001215
Rep. Miller-Meeks, Mariannette [R-IA-1]
Mariannette
Miller-Meeks
R
IA
1
2025-02-04
True
- K000375
Rep. Keating, William R. [D-MA-9]
William
Keating
D
MA
R.
9
2025-02-04
True
- H001067
Rep. Hudson, Richard [R-NC-9]
Richard
Hudson
R
NC
9
2025-02-04
True
- T000488
Rep. Thanedar, Shri [D-MI-13]
Shri
Thanedar
D
MI
13
2025-02-04
True
- B001257
Rep. Bilirakis, Gus M. [R-FL-12]
Gus
Bilirakis
R
FL
M.
12
2025-02-04
True
- G000583
Rep. Gottheimer, Josh [D-NJ-5]
Josh
Gottheimer
D
NJ
5
2025-02-04
True
- S001199
Rep. Smucker, Lloyd [R-PA-11]
Lloyd
Smucker
R
PA
11
2025-04-07
False
- B001326
Rep. Bynum, Janelle [D-OR-5]
Janelle
Bynum
D
OR
S.
5
2025-04-07
False
- K000398
Rep. Kean, Thomas H. [R-NJ-7]
Thomas
Kean
R
NJ
H.
7
2025-04-07
False
- T000468
Rep. Titus, Dina [D-NV-1]
Dina
Titus
D
NV
1
2025-04-07
False
- S001226
Rep. Salinas, Andrea [D-OR-6]
Andrea
Salinas
D
OR
6
2025-05-20
False
- D000628
Rep. Dunn, Neal P. [R-FL-2]
Neal
Dunn
R
FL
P.
2
2025-05-20
False
- G000605
Rep. Gray, Adam [D-CA-13]
Adam
Gray
D
CA
13
2025-06-12
False
- C001120
Rep. Crenshaw, Dan [R-TX-2]
Dan
Crenshaw
R
TX
2
2025-06-12
False
- B001327
Rep. Bresnahan, Robert P. [R-PA-8]
Robert
Bresnahan
R
PA
P.
8
2025-09-30
False
Health
- Health care costs and insurance
2025-04-11T16:08:56Z
- Medicare
2025-04-11T16:08:56Z
- Prescription drugs
2025-04-11T16:08:56Z
Health
2025-03-07T16:20:09Z
00
2025-02-04
Introduced in House
2025-05-08T19:40:40Z
Optimizing Research Progress Hope And New Cures Act or the ORPHAN Cures Act
This bill modifies certain provisions under the Medicare Drug Price Negotiation Program with respect to orphan drugs.
The Medicare Drug Price Negotiation Program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. The program does not apply to orphan drugs that are approved to treat only one rare disease or condition.
The bill modifies these provisions so as to exclude any period in which a drug was an orphan drug from market approval calculations. It also excludes orphan drugs that are approved to treat more than one rare disease or condition from the program.

ORPHAN Cures Act
- Display Title
45

ORPHAN Cures Act
2025-03-05T10:08:22Z
- Short Title(s) as Introduced
101

ORPHAN Cures Act
2025-03-05T10:08:19Z
Introduced in House
IH
- Short Title(s) as Introduced
101

Optimizing Research Progress Hope And New Cures Act
2025-03-05T10:08:19Z
Introduced in House
IH
- Official Title as Introduced
6

To amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.
2025-03-05T10:03:51Z
Introduced in House
IH
- Introduced in House
2025-02-04T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-119hr946ih/xml/BILLS-119hr946ih.xml
2025-02-06
Sponsor introductory remarks on measure. (CR H535-536)
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.